Mycobacterium avium Complex (MAC) Lung Disease

Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease

Post author:Anna Hewitt
Post published:October 5, 2018
Post category:Mycobacterium avium complex infection Nontuberculous Mycobacteria (NTM) Lung Diseas

A new drug designed to treat MAC lung disease as part of a combination antibacterial drug regimen in adults with limited treatment options has been granted Accelerated Approval by the…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More